Session Item

Saturday
May 07
08:00 - 08:40
Room D5
Monte Carlo dose calculation in modern day radiotherapy
Jenny Bertholet, Switzerland
1060
Teaching lecture
Physics
15:00 - 15:15
Against the motion rebuttal: Brachytherapy Boost for Prostate Cancer - A Diminishing Solution
SP-0032

Abstract

Against the motion rebuttal: Brachytherapy Boost for Prostate Cancer - A Diminishing Solution
Authors:

Jarad Martin1, Mark Sidhom2, David Pryor3, Colin Tang4, Amy Hayden5, Andrew Miller6, Swetha Sridaran7, Yuvnik Trada7, Anne Capp8, Peter Greer9, Paul Keall10, Shankar Siva11, Jonathan Tomaszewski12

1Calvary Mater Newcastle, Department of Radiation Oncology, Newcastle, Australia; 2Liverpool Hospital, Department of Radiation Oncology, Sydney, Australia; 3Princess Alexandra Hospital, Radiation Oncology, Brisbane, Australia; 45D Clinics, Radiation Oncology, Perth, Australia; 5Westmead Hospital, Radiation Oncology, Sydney, Australia; 6Illawarra Cancer Care Centre, Radiation Oncology, Wollongong, Australia; 7Calvary Mater Newcastle, Radiation Oncology, Newcastle, Australia; 8GenesisCare Gateshead, Radiation Oncology, Newcastle, Australia; 9University of Newcastle, Medical Physics, Newcastle, Australia; 10University of Sydney, Image X Institute, Sydney, Australia; 11Peter MacCallum Cancer Centre, Radiation Oncology, Melbourne, Australia; 12Ballarat Austin Radiation Oncology Centre, Radiation Oncology, Ballarat, Australia

Show Affiliations
Abstract Text

Prostate cancer dose escalation was pioneered in the 1980s and 90s with brachytherapy.  As external beam approaches have become more sophisticated alongside better functional staging investigations and integration of systemic therapies, the use of brachytherapy has been declining world wide.  Although we recognize the valuable lessons learnt from the brachytherapy literature, the field is evolving in different directions which we will explore in this debate.